Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
about
Relationship of an advanced glycation end product, plasma carboxymethyl-lysine, with slow walking speed in older adults: the InCHIANTI study.Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging.Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.Serum carboxymethyllysine, an advanced glycation end product, and age-related macular degeneration: the Age, Gene/Environment Susceptibility-Reykjavik StudyAdvanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adultsEndogenous secretory receptor for advanced glycation end products and chronic kidney disease in the elderly population.Serum carboxymethyl-lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults.Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women.Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adultsSerum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults.Circulating levels of carboxy‐methyl‐lysine (CML) are associated with hip fracture risk: the Cardiovascular Health StudyCirculating selenium and carboxymethyl-lysine, an advanced glycation endproduct, are independent predictors of anemia in older community-dwelling adultsRelationship of a dominant advanced glycation end product, serum carboxymethyl-lysine, and abnormal glucose metabolism in adults: the Baltimore Longitudinal Study of AgingElevated Serum Carboxymethyl-Lysine, an Advanced Glycation End Product, Predicts Severe Walking Disability in Older Women: The Women's Health and Aging Study IDietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics StudyCarboxymethyl lysine, an advanced glycation end product, and incident diabetes: a case-cohort analysis of the ARIC Study.Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling womenCarboxymethyl-lysine, an advanced glycation end product, and decline of renal function in older community-dwelling adultsElevated serum advanced glycation end products and poor grip strength in older community-dwelling womenElevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women.Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults.Advanced glycation end products on stored red blood cells increase endothelial reactive oxygen species generation through interaction with receptor for advanced glycation end products.
P2860
Q33603990-F85669D9-B812-4320-83E9-946AA4EB527EQ33691339-4383CCE4-3CC6-499D-B2A4-2C4B2B225C08Q33752140-2FBC1C8E-9C3A-46BE-8D4C-9DA8F2FD8D7BQ33904838-747416E9-1D1B-4E22-902D-10D6FEAB6FC9Q34213760-803E41A3-7ABF-4F9F-B4E0-6D611F9D6C69Q34217710-B2F24E88-68EE-4E98-A94E-1F9B8E51DC8FQ34724954-76B7010C-64A2-4141-81A5-A90E178B23E5Q34885399-DEABD125-A385-4EFF-868D-7A1AA6A956DAQ34981419-F94B0533-E4D6-46F5-B5F7-6D07E51A5068Q35173430-098A38D9-564D-437F-8F50-B958E250129CQ35690158-E4812185-6D20-4C5B-A8D3-66250EBDE4F9Q35911173-83F721E4-522E-42D2-8664-73018DC8BDB9Q36040868-EB0D8D6B-17E6-4D0E-A74B-9CD3D2ED180FQ36212513-E4D054E8-CC51-4A9B-BE4E-483FD411C4EFQ36220872-98B37F50-4803-4ED5-952F-F0B299D98A21Q36364486-E3CD1A48-E49E-4C99-88C8-09C2B780A87EQ37056383-61B68F59-47EB-4E60-A0C9-47B30FCA8DEBQ37088388-102C525B-D794-4E91-8103-0B9BC016A5C7Q37088397-796FD614-8AFC-4B08-ABD9-09EE43D06138Q37103996-2F7CA519-96FB-4E83-B90F-5F34E1ED3399Q37300130-8043AAF1-293E-428E-9B6F-8D5F3E37F93EQ37445850-A4A8D9E3-1651-45BB-ADC1-AEE28DC2F281Q41478232-41CFDF3C-E91E-4ADB-875B-28B4776E1715
P2860
Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Two immunochemical assays to m ...... serum from dialysis patients.
@en
Two immunochemical assays to m ...... serum from dialysis patients.
@nl
type
label
Two immunochemical assays to m ...... serum from dialysis patients.
@en
Two immunochemical assays to m ...... serum from dialysis patients.
@nl
prefLabel
Two immunochemical assays to m ...... serum from dialysis patients.
@en
Two immunochemical assays to m ...... serum from dialysis patients.
@nl
P2093
P2860
P356
P1476
Two immunochemical assays to m ...... serum from dialysis patients.
@en
P2093
Helga Stopper
Katharina Steinmann
Matthias Frischmann
Monika Pischetsrieder
Rose Kientsch-Engel
Toshimitsu Niwa
Xiaohong Zhang
P2860
P304
P356
10.1515/CCLM.2005.089
P577
2005-01-01T00:00:00Z